Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

YPEL3 Inhibitors

YPEL3 inhibitors are chemical compounds designed to target and inhibit the activity of the YPEL3 protein, which is part of the YPEL (Yippee-like) family of evolutionarily conserved proteins. YPEL3 is known to play a role in cellular processes such as cell growth regulation and differentiation, particularly in the context of cell cycle control. The YPEL family members, including YPEL3, have been found to possess conserved domains that suggest roles in various molecular pathways associated with cellular proliferation and structural integrity. YPEL3, in particular, is involved in promoting cell cycle arrest in certain contexts, and its inhibition can affect how cells progress through different stages of growth and division. It is thought to act as a modulator of signaling pathways that contribute to the regulation of cellular proliferation and the maintenance of homeostasis.

Inhibitors of YPEL3 work by disrupting the protein's function, leading to interference in the pathways where YPEL3 is actively involved. These inhibitors typically function by binding to specific regions of the YPEL3 protein, thus blocking its ability to interact with other molecular partners or execute its biological functions. This disruption can have downstream effects on the regulation of gene expression and protein synthesis, particularly those involved in the cell cycle. Since YPEL3 plays a key role in controlling cellular growth and differentiation, its inhibition could potentially lead to changes in the way cells respond to growth signals or environmental stressors. The detailed study of YPEL3 inhibitors provides insights into their structural features, mechanisms of action, and the broader implications of modulating YPEL3 activity at a molecular level, particularly regarding how it influences complex intracellular processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K, reducing AKT phosphorylation which is upstream of YPEL3, leading to decreased YPEL3 stabilization.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK inhibitor that prevents ERK pathway activation, subsequently downregulating YPEL3 expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor, altering the stress response pathway that can control YPEL3 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, modifying the AP-1 transcription factor activity, which regulates YPEL3 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that affects YPEL3 by altering the protein synthesis machinery and potentially its expression levels.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Proteasome inhibitor that can increase cellular levels of ubiquitinated proteins, indirectly influencing YPEL3 degradation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor that can stabilize proteins targeted for degradation, affecting YPEL3 turnover.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK, which is involved in the ERK pathway, leading to reduced transcription of YPEL3.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor that impedes AKT activation, thereby influencing YPEL3's stabilization and function.

IKK 16

1186195-62-9sc-204009
sc-204009A
10 mg
50 mg
$219.00
$924.00
2
(1)

Inhibits NF-κB activation, which can modulate YPEL3 expression by affecting transcription.